 Diabetes A to Z - Prevention, Management, and Digital Advances Dear Renukaprasad A R,
The last few decades have seen a dramatic increase in the incidence of diabetes and its associated comorbidities. The introduction of digital tools, including artificial intelligence and machine learning, has proven to be an invaluable addition to our fight against diabetes, both in clinical and research-based settings. Keeping abreast of the latest developments in the management of diabetes and incorporating them into patient care can significantly help improve the quality of life of diabetic patients.
Join our panel of experts for an exciting ACME session entitled "Diabetes A to Z - Prevention, Management, and Digital Advances" and earn 1 point on 13th November, 2:00 PM IST onwards.
Session highlights:
- Primordial Prevention in Diabetes: New Age Ideas - Dr. Chittaranjan Yajnik
- Neuropathic Foot Ulcers - Dr. Arati Shahade
- Daily Practicalities of Digital Diabetology - Dr. A G Unnikrishnan
Brain Matters in Diabetes Patients with type 1 and type 2 diabetes have been shown to have mild to moderate reductions in cognitive function. This association between diabetes and lower cognitive functions is primarily mediated by markers of both neurodegeneration and cerebrovascular disease. With the ever-increasing incidence of diabetes worldwide, there is an urgent need to understand the complex interplay between the central nervous system and peripheral insulin regulation.
Want to know more? Join the renowned physicians, Dr. Harish Ramchandra Joshi and Dr. Rahul Kulkarni, in our exclusive Global Diabetes Summit as they discuss "Brain Matters in Diabetes" on 13th November, 6:00 PM IST onwards. A-302, Teerth Technospace, Mumbai-Bengaluru Highway, Baner,
Pune-411045, India. +91-9850036954 |
.png "Docplexuslogo")
No comments:
Post a Comment